Cargando…
Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables
OBJECTIVE: To propose appropriate statements that drive the choice of biologic therapies in patients with rheumatoid arthritis (RA), factoring in their impact on the following issues: anti-drug antibody (ADAb) formation, suspicion and management of infections, lupus-like syndrome (LLS), effects on b...
Autores principales: | Niccoli, Laura, Nannini, Carlotta, Blandizzi, Corrado, Mantarro, Stefania, Mosca, Marta, Di Munno, Ombretta, Goletti, Delia, Benucci, Maurizio, Gobbi, Francesca Li, Cassarà, Emanuele, Kaloudi, Olga, Cantini, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207089/ https://www.ncbi.nlm.nih.gov/pubmed/30498353 http://dx.doi.org/10.2147/TCRM.S175772 |
Ejemplares similares
-
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study
por: Cantini, Fabrizio, et al.
Publicado: (2012) -
Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study
por: Cantini, Fabrizio, et al.
Publicado: (2013) -
Systemic autoimmune disease in asbestosis rapidly responding to anti-interleukin-1beta antibody canakinumab: a case report
por: Niccoli, Laura, et al.
Publicado: (2015) -
Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients
por: Cantini, Fabrizio, et al.
Publicado: (2012) -
Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
por: Cantini, Fabrizio, et al.
Publicado: (2017)